Literature DB >> 4529565

Electrophysiological mechanism of the short PR interval in Pompe disease.

P C Gillette, M R Nihill, D B Singer.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4529565     DOI: 10.1001/archpedi.1974.02110300032005

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


× No keyword cloud information.
  5 in total

1.  Cardiac Pathology in Glycogen Storage Disease Type III.

Authors:  S L Austin; A D Proia; M J Spencer-Manzon; J Butany; S B Wechsler; P S Kishnani
Journal:  JIMD Rep       Date:  2012-01-31

2.  The conduction system in Pompe's disease.

Authors:  S Bharati; M Serratto; I DuBrow; M H Paul; S Swiryn; R A Miller; K Rosen; M Lev
Journal:  Pediatr Cardiol       Date:  1982       Impact factor: 1.655

3.  Combined general and epidural anesthesia for major abdominal surgery in a patient with Pompe disease.

Authors:  Won Sung Kim; Ah Reum Cho; Jung Min Hong; Eun Soo Kim; Sung Chun Park; Ji Young Yoon; Tae Kyun Kim
Journal:  J Anesth       Date:  2010-07-09       Impact factor: 2.078

4.  Electrocardiographic and other cardiac anomalies in beta-glucuronidase-null mice corrected by nonablative neonatal marrow transplantation.

Authors:  A J T Schuldt; T J Hampton; V Chu; C A Vogler; N Galvin; M D Lessard; J E Barker
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-02       Impact factor: 11.205

5.  Pompe disease diagnosis and management guideline.

Authors:  Priya S Kishnani; Robert D Steiner; Deeksha Bali; Kenneth Berger; Barry J Byrne; Laura E Case; Laura Case; John F Crowley; Steven Downs; R Rodney Howell; Richard M Kravitz; Joanne Mackey; Deborah Marsden; Anna Maria Martins; David S Millington; Marc Nicolino; Gwen O'Grady; Marc C Patterson; David M Rapoport; Alfred Slonim; Carolyn T Spencer; Cynthia J Tifft; Michael S Watson
Journal:  Genet Med       Date:  2006-05       Impact factor: 8.822

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.